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The prevalence of depression increases with aging. We hypothesized that like humans, old animals exhibit
anhedonic-like behavior, along with signs of behavioral despair. In rodents, anhedonia, a reduced sensitivity
to reward, which is listed as a core feature of major depression in the DSM-IVR, can be measured by a de-
crease in intake of and preference for sweet solutions. Here, sucrose intake, forced swimming, immobility
in the modiﬁed tail suspension test, novelty exploration, grooming, anxiety and locomotor activity were com-
pared in naïve 3- and 18-month-old male C57BL/6 mice. The absolute amounts and the ratio of consumed 1%
sucrose solution to water intake was signiﬁcantly smaller in 18-month-old mice than in 3-month-old mice.
The consumption of 5%-sucrose solution requiring high levels of drinking effort, novelty exploration in two
setups and grooming behavior in the splash test were reduced in older animals. Analysis of other behaviors
suggested that the above-mentioned signs of anhedonic-like traits were unlikely to be attributable to the po-
tential effect of aging on metabolic needs for water, taste perception, motor capabilities or the induction of
essential anxiety and neophobia. A 4-week treatment with the antidepressant imipramine (7 mg/kg/day)
or dimebon, a compound with suggested neuroprotective proneurogenic properties (1 mg/kg/day) restored
sucrose intake and preference in 18-month-old mice. Meanwhile, young and old mice showed no differences
in the parameters of behavioral despair evaluated in the forced swim and modiﬁed tail suspension tests.
Thus, the behavioral proﬁle of aged mice parallels that of humans with elderly depression, in whom the
symptoms of hedonic deﬁcits typically outweigh affective disturbances. The assessment of anhedonic-like
traits with the sucrose preference test in 18-month-old mice will be useful in preclinical studies of elderly
depression.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
The prevalence of depression is elevated in older people (Zanni and
Wick, 2010; Glaesmer et al., 2011). The overall aging of the population
suggests an increase in the social impact of elderly-related depressive
disorders (Solhaug et al., 2011). According to the DSM-IVR, the cardinal
symptom of major depression is clinically observed anhedonia, the de-
creased ability to experience pleasure, which is observed alongwith sub-
sidiary features including affective disturbances (Hamilton, 1967; Klein,
1974). We hypothesized that old mice, like humans, exhibit anhedonic-
like features and signs of behavioral despair when compared to younger
animals and that these changes are sensitive to antidepressant treatment.
Both features of a depressive-like state are likely to occur in parallel
(Fonken et al., 2009; Snyder et al., 2011). For example, anhedonia-like
behavior deﬁnedby adecrease in sucrose intake andpreference in chron-
ically stressed C57BL/6Nmice accompanies an increase in ﬂoating during
forced swimming and immobility behavior in the modiﬁed tail suspen-
sion test (Strekalova et al., 2004; Strekalova and Steinbusch, 2010;
Kanarik et al., 2011). These changes are often associatedwith a reduction
in novelty exploration and grooming behavior in the splash test
(Strekalova et al., 2004; Skrinskaia and Nikulina, 1994; Pothion et al.,
2004). Antidepressant treatment counteracts the above-mentioned
depressive-like traits in rodents (Porsolt and Papp, 1998; Willner, 2005;
Strekalova et al., 2011; Yacoubi et al., 2011; Surget et al., 2008).
A body of evidence suggests that older mice and rats have reduced
interest in various hedonic stimuli, such as palatable food and drink-
ing solutions, alcohol and a regular diet (Spear and Varlinskaya, 2010;
Blanton et al., 1998). In the chronic stress model, older rats showed
enhanced susceptibility to anhedonic-like changes in a sucrose test
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and a delayed response to the antidepressant effects of citalopram
(Herrera-Pérez et al., 2008, 2010). Aging in rodents resulted in dimin-
ished place preference conditioned to a food (Rubinow et al., 2009),
nicotine, cocaine, morphine and alcohol (Vastola et al., 2002; Campbell
and Wood, 2000). It is also associated with lower novelty exploration
(Vastola et al., 2002; Campbell and Wood, 2000) and decreased scores
of grooming (Scimonelli et al., 1999; Shoji and Mizoguchi, 2011),
which are considered to reﬂect a reduced self-rewarding activity
(Pothion et al., 2004; Dubreucq et al., 2010; Gómez-Lázaro et al., 2011;
Park et al., 2011). Together, these ﬁndings from animal studies parallel
clinical features of elderly depression, which are predominantly related
to hedonic deﬁcits (Gallo et al., 1994, 1997).
Though affective disturbances are less typical of sentient depres-
sion (Lawton et al., 1996), translational studies report elevated scores
of behavioral despair in elderly animal cohorts (Frye and Walf, 2009;
Moretti et al., 2011). In the paradigm of operant extinction of escape
from water, the removal of the platform in the Morris water maze in-
duces higher scores of ﬂoating behavior in 24-month-old Wistar rats
than in younger animals (Schulz et al., 2007). Similarly, the enhance-
ment of ﬂoating behavior in the forced swim test evoked in BALB/c
mice by lipopolysaccharide is two-fold higher in 20- to 24-month-
old than in 3-month-old animals (Godbout et al., 2008).
The present study examined the parameters of reward sensitivity
and behavioral despair in 18-month-old versus 3-month-old male
mice of the C57BL/6N strain, which is commonly used in translational
research on depression. The available literature suggests that aged
rats and mice of various strains with behavioral signs of hedonic
and affective deﬁcits also show psychomotor disturbances when test-
ed at certain ages (Schulz et al., 2007; Sofﬁé et al., 1992; Bowman et
al., 2006), but not at others (Frye and Walf, 2009; Moretti et al.,
2011; David et al., 2001; Gould and Feiro, 2005). The efﬁcacy of differ-
ent classes of antidepressants also depends on the age of the experi-
mental animals (Bourin et al., 1998). The use of animals within the
age range at which depressive-like features emerge while general
age-related behavioral changes are still minimal, and, thus, can be ig-
nored, is important for minimizing confounding factors in rodent
models of elderly depression. Our preliminary experiments demon-
strated that depressive-like behaviors are accompanied by general
locomotor and consumatory abnormalities in 25- but not 18-month-
old C57BL6/N mice (Bolkunov et al., 2009). To determine whether
18-month-old animals display depressive features without generalized
psychomotor deﬁcits, they were compared to 3-month-old mice in an
extended test battery for commonly used measures of anhedonia, be-
havioral despair, anxiety-like behavior, grooming, exploration and loco-
motion (Pothion et al., 2004; Surget et al., 2008; Strekalova, 2008;
Strekalova and Steinbusch, 2009).
Clinical studies show that the symptoms of hedonic deﬁcit typically
outweigh affective disturbances in patientswith elderly depression. The
self-reported “lack in positive affect” is consistent in elderly patients
with major depression, while the emergence of “negative affect” is var-
iable (Lawton et al., 1996). Older primarily depressed patients were less
likely to endorse crying spells, sadness, feeling fearful, being bothered,
or feeling like a failure, and were less likely to have co-morbid anxiety,
but tended to experience poor appetite and loss of interest in sex
(Hybels et al., 2011). A study of more than 6500 participants showed
that persons aged 65 years and older were less likely to acknowledge
dysphoria than anhedonia (Gallo et al., 1994). A 13-year follow-up
study of more than 1500 depressed patients aged 50 years and older
revealed the signiﬁcant prevalence of a form of disorder whose core
criteria included hedonic deﬁcit but not sadness or dysphoria (Gallo et
al., 1997).
We therefore addressed whether both anhedonic and affective fea-
tures change in C57BL6mice of 18-month-old age. Anhedonic behavior
deﬁned by decreased sucrose intake and preference on one hand, and
signs of behavioral despair in the forced swim andmodiﬁed tail suspen-
sion tests on the other, have been extensively validated as parameters of
reward sensitivity and affective traits inmice and rats (Porsolt and Papp,
1998;Willner, 2005; Strekalova et al., 2011; Yacoubi et al., 2011). In sum,
using these paradigms and additional tests, the present study examined
whether, in comparison with 3-month-old mice of the C57BL6N strain,
18-month-old mice (1) exhibit changes indicative of the depressive
state in the sucrose test, novelty exploration, splash test, forced swim
and modiﬁed tail suspension paradigms, (2) show the prevalence of
one type of deﬁcit, hedonic- or affective-like, over the other, whether
(3) older animals have disturbances in daily liquid intake, anxiety-like
behavior and locomotion that are non-speciﬁc to depressive-like traits
and (4) parameters of depressive-like behavior in aged animals are
sensitive to antidepressant treatment.
In addition to a classical antidepressant imipramine, we also assessed
the effects of dimebon, an investigational drug against Alzheimer's and
Huntington's diseases with proposed proneurogenic neuroprotective
properties. Dimebon, a tetrahydro-g-carboline with anti-histamine ef-
fects, was reported to block the apoptosis of cortical neurons (Bachurin
et al., 2001), protect the mitochondrial membrane potential (Bachurin
et al., 2003; Pieper et al., 2010), promote neurite outgrowth in cultured
hippocampal and cortical neurons (Protter et al., 2009; Bernales et al.,
2009), dose-dependently increase neurogenesis in the rat dentate gyrus
(Pieper et al., 2010), act in vitro as a low-afﬁnity NMDA receptor blocker
via the NR2B subunit (Perlovich et al., 2009) and enhancememory prop-
erties inmiddle-agedmice (Vignisse et al., 2011). The role of these factors
in the neurobiology of depression was generally documented (Skolnick
et al., 2009; Pittenger and Duman, 2008; Marcocci et al., 2002), however,
it remains to be studiedwhether dimebonmay exert any systemic effects
via these mechanisms (Bachurin, 2003).
2. Material and methods
2.1. Animals, housing and general experimental conditions
Three- and 18-month-old C57BL/6N mice were used in this study.
Following purchase from the supplier, mice were housed in individual
cages for at least 2 weeks before testing. Standard laboratory conditions
(22±1 °C, 55% humidity, food and water ad libitum) and a reverse
12 h:12 h light–dark cycle (lights on: 21:00 h)were applied throughout
the study. Micewere tested during the dark period of the light cycle. All
experiments were carried out in accordance with the European Com-
mittees Council Directives.
2.2. Study design
2.2.1. Experiment 1: study of behavioral measures of hedonic sensitivity
in old versus young mice
Experiment 1 examined the consumption of palatable solutions by
old versus young mice using two paradigms of the sucrose intake test.
A decrease in sucrose intake and preference over water is generally
taken as a putative sign of anhedonia in rodents (Strekalova and
Steinbusch, 2010; Porsolt and Papp, 1998; Willner, 2005). This experi-
ment aimed to investigate the effects of aging on behavioral measures
of hedonic status in mice. Three- and 18-month-old mice were tested
in a two-bottle free-drinking paradigm with a 1% sucrose solution (see
Section 2.3.1). Experimental groups comprised 15 mice, body weight
was compared to young and old mice. To estimate liquid intake during
aging, 24-h water consumption was compared between two groups in
a separate test; each group comprised 10 animals (see Section 2.3.2).
The consumption of a 5% sucrose solution requiring a high level of
drinking effort from a bottle with a narrow nipple was then assessed
in young versus old animals in a one-bottle paradigm (see Section
2.3.3, ﬁve animals in each group). In order to assess the ability of
sweet taste of older mice, the intake of a 5% sucrose solution from
regular bottles was evaluated one week earlier in two groups of
mice in a free-access one-bottle paradigm (see Section 2.3.3). In
order to compare the physical ability of young and old mice to drink
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in a situation that required high levels of effort, their water intake was
estimated on the fourth day thereafter (between the two tests on su-
crose intake; see Section 2.3.3).
2.2.2. Experiment 2: study of parameters of behavioral despair during
aging
Experiment 2 scored parameters of behavioral despair in younger
and older mice tested for hedonic sensitivity in the modiﬁed forced
swim (Section 2.3.4) and the modiﬁed tail suspension (Section
2.3.5) tests; behavior was videotaped. First, CleverSys software
(CleverSys, Reston, VA, USA) was applied for automated scoring of
the ﬂoating and immobility behaviors, as well as the duration of
swimming in the forced swim test and of locomotor activity in the
modiﬁed tail suspension test. The duration of climbing behavior and
the number of diving events were scored supplementary in the forced
swim test. Automated scoring of behaviors was analyzed per 1-
minute interval and per entire scoring period; for technical reasons,
only the ﬁrst 5 min were scored (see Sections 2.3.4 and 2.3.5).
Second, the latencies of the ﬁrst episodes of ﬂoating and immobility
behavior, as well as the duration of these behaviors, were scored man-
ually off-line. Both tests were validated pharmacologically for sensitivi-
ty to antidepressant treatment. In a separate validation study, 10 mice
at the age of 3 months were treated either with a single acute i.p. injec-
tion of imipramine at the dose 30 mg/kg 30 min prior to the ﬁrst expo-
sure to a forced swim or modiﬁed tail suspension tests, or with vehicle
(see Section 2.4) Behavior was scored as described below (see Sections
2.3.4 and 2.3.5). This schemeof pharmacological validationwas adapted
from originally published studies with tricyclics in these tests (Steru et
al., 1985, 1987; Porsolt et al., 1987). To enable a data comparison from
two experiments, data obtained on oldermice and on pharmacological-
ly treated mice were normalized to themeans of values of younger and
vehicle-treated 3-month-old mice, respectively.
2.2.3. Experiment 3: study of parameters of locomotion, exploration,
grooming and anxiety
Experiment 3 examined potential aging-related changes in the
parameters of anxiety and locomotion that could interfere with the
evaluation of depressive-like behaviors. Grooming behavior and three
parameters of novelty exploration were scored in groups of both ages
in the splash test, the True scan open-ﬁeld and novel cage tests to
further assess the hedonic/motivational state of old mice. Three- and
18-month-old mice were analyzed in the True scan open-ﬁeld, novel
cage, O-maze and dark/light box (n=12 and n=11, respectively; see
Sections 2.3.6–2.3.10) and in the splash test (n=15 in each group;
see Section 2.3.8).
2.2.4. Experiment 4: effects of imipramine and dimebon on hedonic and
affective behaviors
In Experiment 4, we investigated whether the classical antide-
pressant imipramine and potentially neuroprotective proneurogenic
drug dimebon administered to 18-month-old mice for 4 weeks at
the doses 7 mg/kg/day and 1 mg/kg/day, respectively, affected the
parameters of the sucrose preference test, the latter indicating the
state of anhedonia. These animals were tested for ﬂoating and immo-
bility in visually scored modiﬁed forced swim and modiﬁed tail sus-
pension tests (see Sections 2.3.4 and 2.3.5). The dose of imipramine
was based on previous studies with CD1mice, in which its chronic ad-
ministration at 7 mg/kg/day effectively reduced the stress-induced
decrease in sucrose intake and preference, ﬂoating behavior and al-
teration of hippocampal gene expression typical of the subgroup of
mice susceptible to anhedonia (van Miegem et al., 2009). The dosage
of dimebon was determined according to its efﬁcacy in clinic (Doody
et al., 2008), as well as in improving learning in the Morris water
maze paradigm in aged Wistar rats treated with 1 mg/kg/day of this
compound for 3 weeks (Lermontova et al., 2000) and in C57BL6N
mice in a step-down avoidance and conditioned fear extinction tests
(Vignisse et al., submitted for publication). Drugs were delivered in
the drinking water (see Section 2.4).
Body weight and baseline behaviors, including the initial prefer-
ence for a 1% sucrose solution (see Section 2.3.1), were evaluated in
order to form experimental groups which are initially balanced in
these parameters, as described elsewhere (Strekalova et al., 2006).
Each group comprised 5 to 10 mice, the number of animals being in-
dicated in the legend of Fig. 5.
2.3. Behavioral tests
2.3.1. Two-bottle sucrose preference test
Mice of both ages were simultaneously given a free choice be-
tween two bottles, one with 1% sucrose solution and another with
tap water, for 8 h, between 09.00 and 17.00. The beginning of the
test started with the onset of the dark (active) phase of the animals'
cycle. No previous food or water deprivation was applied before the
test. To minimize the spillage of liquids during the sucrose test, spe-
cially manufactured bottles with a glass tip (length of 6 cm, internal
diameter 2 mm; they were inserted in ﬂavorless rubber bottle-
stoppers) were used. Special attention was devoted to sugar storage
to avoid its contact with ﬂavors and plastic, and to washing of bottles,
whereminimal amounts of detergent were used. Bottles were ﬁlled in
advance (during the preceding evening) and were kept upside down
for at least 12 h prior to testing. In order to balance the air tempera-
ture between the room and the drinking bottles, they were kept in
the same room where the testing took place. This measure prevents
the physical effect of liquid leakage resulting from growing tempera-
ture of air and pressure inside the bottles, when they are ﬁlled with
liquids which are cooler than the room air. To prevent the possible ef-
fects of a side-preference in drinking behavior, the position of the bot-
tles in the cage was switched after 4 h during the test. The test was
carried out before weekly cage change. With this method proposed,
the error of measurement of liquid intake does not exceed 0.1 ml.
The intake of water and 1%-sucrose solution and total intake was
estimated by weighing the bottles before and after access to liquids.
The preference for sucrose was calculated as the percentage of the su-
crose solution consumed out of the total amount of liquid drunk:
Sucrose Preference
¼ V Sucrose solutionð Þ=V Sucrose solutionð Þ þ V Waterð Þ½   100%
Changes in sucrose preference in C57BL/6N mice evaluated using
the above-described protocol correlated with molecular, electrophys-
iological, behavioral and biochemical alterations characteristic of a
depressive-like state (Strekalova et al., 2011). Further details of
methodological conditions were applied as described elsewhere
(Strekalova and Steinbusch, 2010).
2.3.2. Daily water intake in one-bottle drinking test
A 24-h water drinking test was carried out simultaneously in both
groups of mice in a one-bottle paradigm starting at 17.00. Specialized
drinking bottles such as those employed in the above-described su-
crose test (see Section 2.3.1) were used. A test procedure was carried
out as described elsewhere (Strekalova and Steinbusch, 2010). The
same precautions concerning possible liquid spillage as in the sucrose
test were applied: bottles were ﬁlled with tap water in advance and
kept in the experimental room 12 h prior to the test, being held up-
side down during this time. The intake of water was estimated by
weighing the bottles before and after access to liquids. The test was
carried out two days before weekly cage change.
2.3.3. Sucrose and water intake in high-effort and free-access one-bottle
drinking tests
In a high-effort one-bottle drinking paradigm, the amount of con-
centrated sucrose solution ingested is taken as a measure of the
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animal's motivation to receive a pleasurable stimulus. In this test,
mice of both ages were simultaneously given access to a 5% sucrose
solution or tap water for 8 h (between 09.00 and 17.00 h), the inges-
tion of which required a high level of effort due to the narrow bottle
tip, the internal diameter of which was 1.0 mm instead of 2.0 mm as
in a regular bottle. Preliminary studies showed that this modiﬁcation
resulted in a reduction in the 24-h water intake of at least 50% of
normal amounts. The consumption of sucrose solutions from these
bottles was high, suggesting that it can be used to measure animals'
effort/motivation to receive a reward. The intake of a 5% sucrose solu-
tion was also evaluated in a single-bottle free-drinking paradigm
using regular bottles for 8 h. The intake of water and sucrose solution
was estimated by weighing the bottles before and after access to
liquids.
2.3.4. Forced swim test
The test protocol was adapted from a previously described procedure
with minor modiﬁcations (Porsolt and Papp, 1998; Strekalova et al.,
2005; Ducottet et al., 2004). Mice were subjected to two 6-min swim-
ming sessions spaced 24 h apart in a transparent cylinder (Ø 17 cm)
ﬁlled with water (+23 °C, water height 13 cm, height of cylinder
20 cm, illumination intensity 25 lx). The slightly deeper water used in
our protocol was shown to increase test sensitivity (Cryan et al.,
2005a). First, by means of the data from the automated scoring system,
the duration of ﬂoating, swimming and climbing behavior and the num-
ber of diving events during the ﬁrst ﬁveminutes and during one-minute
intervals within the scoring period were analyzed (see Section 2.2.2).
Second, scoring by visual observation was carried out by two inde-
pendent observers who were blinded with regard to the animals' age
and treatment (where applicable). The latency of the ﬁrst episode of
ﬂoating and the duration of ﬂoating behavior were recorded during
2-min intervals within the 6-min swimming session and for a total
period on day 1 and day 2 of the test (see Section 2.2.2). Floating be-
havior was deﬁned in accordance with the commonly accepted
criteria of this behavior. Namely, a mouse was considered to be ﬂoat-
ing when only slight movements of its limbs and tail could be
detected, without signs of searching activity; passive movements of
the body while drifting on the surface of the water have no direction
(Strekalova et al., 2005; Ducottet et al., 2004; Cryan et al., 2005a;
Mineur et al., 2006). Latency of ﬂoating was determined as the time
between the placement of a mouse in a water tank and the ﬁrst
bout of ﬂoating behavior.
2.3.5. Modiﬁed tail suspension test
The protocol used in this study was adapted from a previously
proposed procedure (Mineur et al., 2006). Mice were subjected to the
modiﬁed tail suspension by being hung by their tails with adhesive
tape to a rod 50 cm above the ﬂoor for 6 min. Two animals were tested
simultaneously in a dark room where only the area of the modiﬁed tail
suspension constructionwas illuminated by a spotlight from the ceiling;
the lighting intensity on the height of themouse positionwas 25 lx. The
trialswere recorded by a video camera positioned directly in front of the
mice while the experimenter observed the session from a distance in a
dark area of the experimental room. This procedure was carried out
twice with a 24-h interval between tests, similarly to previously
reported protocols (Vaugeois et al., 1997; Gavioli et al., 2004). First, dur-
ing the additional automated scoring, the duration of immobility and
activity was scored during the ﬁrst ﬁve minutes and during one-
minute intervals within the scoring period (see Section 2.2.2).
Second, in line with generally accepted protocols, the latency of
the ﬁrst episode of immobility and the total duration of this behavior
were scored manually as described elsewhere (Mineur et al., 2006;
Vaugeois et al., 1997), and the scoring was performed during 2-min
sub-intervals within a 6-min session and summarized for the entire
period on day 1 and day 2 (see Section 2.2.2). Therefore, videotapes
were scored by two independent observers who were blinded with
regard to the animals' age and treatment bymanual analysis, in accor-
dance with the commonly accepted criteria of immobility (Cryan et
al., 2005b; Ibarguen-Vargas et al., 2009). The immobility behavior
was deﬁned as the absence of any movements of the animals' head
and body. The latency of immobility was determined as the time be-
tween the onset of the test and the ﬁrst bout of immobility. The
means of the values obtained by the two observers were analyzed.
2.3.6. TruScan open‐ﬁeld test
Mice were placed into True Scan activity boxes (26 cm×26 cm×
39 cm; Coulbourn Instruments, Allentown, PA, USA) for 10 min. Boxes
were evenly illuminatedwithwhite light, with an illumination intensity
of 25 lx. Horizontal movements (speed), resting time, the duration of
exploration during rearing and of nose poke behavior, were scored au-
tomatically by red beam cells using TruScan software (Coulbourn), as
described elsewhere (Strekalova et al., 2004). Animals were placed in
the experimental room at least 1 h prior to the experiment. The testing
was carried out in the morning between 09.00 and 12.00. Mice of both
ages were tested simultaneously; two animals were used in each run.
Boxes were cleaned with water between the runs.
2.3.7. Novel cage test
Thenovel cage testwas performed to assess exploration of a newen-
vironment, as described elsewhere (Strekalova et al., 2004). Mice were
introduced into a standard plastic cage the size of their home cage ﬁlled
with small amounts of fresh sawdust. The number of exploratory
rearings was counted under red light during a 5-min period. The testing
was carried out in a dark quiet room in morning hours. Behavior was
videotaped and analyzed by trained observers blind to the animals' age.
2.3.8. Splash test
This test was performed as described elsewhere (Pothion et al.,
2004; Surget et al., 2008). A 10% sucrose solution was spread on the
dorsal surface of a mouse coat, which because of its high viscosity in-
duces lasting grooming behavior in mice. As animals were single-
housed, no prior isolation needed to be applied on this occasion.
The parameters generally accepted for splash tests, i.e. latency of
the ﬁrst episode of grooming, number of grooming episodes and du-
ration of grooming behavior, were measured in 3-and 18-month-old
mice by trained observers.
2.3.9. Elevated O-maze
The apparatus (Technosmart, Rome, Italy), which consisted of a cir-
cular path (runway width 5.5 cm, diameter 46 cm), was placed 50 cm
above the ﬂoor. Two opposing arms were protected by walls (height
10 cm), and the illumination strength was 25 lx. The apparatus was
placed on a dark surface in order to reduce reﬂection andmaintain con-
trol over lighting conditions during testing. Anxiety-like behavior was
assessed using previously validated parameters (Strekalova et al.,
2005; Vignisse et al., 2011). Mice were placed in one of the closed-
arm compartments of the apparatus. The latency of the ﬁrst exit to the
anxiety-related open compartments of the maze, the total duration of
time spent therein and the number of exits to the open arms were
scored during a 5-min observation period.
2.3.10. Dark/light box
The dark/light box (Technosmart, Rome, Italy) consisted of two
plexiglass compartments, one black/dark (15 cm×20 cm×25 cm)
and one lit (30 cm×20 cm×25 cm), connected by a tunnel. Anxiety-
like behavior was assessed by earlier validated measures
(Strekalova et al., 2005; Vignisse et al., 2011). Mice were placed into
the dark compartment, fromwhere they could visit the lit box, illumi-
nated by light of 25 lx intensity. The latency of the ﬁrst exit to the
light compartment, the total duration of time spent in the lit box
and the number of visits to this anxiety-related compartment were
scored by visual observation over 5 min.
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2.4. Drugs and drug administration
For a validation study with tests for affective behavior, imipramine
(Sigma Aldrich, St. Louis, MO, USA) was dissolved in water for injec-
tion and administrated to mice via a single i.p. injection at the dose
of 30 mg/kg 30 min prior to the ﬁrst exposure to forced swim or mod-
iﬁed tail suspension tests. The same treatment scheme was applied to
administer a vehicle; the volume of imipramine and vehicle injections
was 0.01 ml/kg.
In the study with 3- and 18-month-old mice, imipramine (from
the same source as in above-mentioned study) and dimebon
(obtained from the Institute of Physiologically Active Compounds,
Chernogolovka, Russia) were administered for 4 weeks via drinking
water at the doses of 7 and 1 mg/kg/day, respectively. Both drugs
were dissolved in tap water; the solutions were changed on average
every 3 and 5 days, respectively. Due to the light sensitivity of imipra-
mine, its solution was renewed more frequently, and the bottles were
covered with aluminum. Calculation of the drug concentrations in
drinking water was based on the means of a 3-day evaluation of
daily water consumption in both groups of mice, which were in fact
similar (Fig. 1D), and on the desirable treatment dosage. This method
of dosing in C57BL6N mice was previously validated in chronic stress
experiments using citalopram (Strekalova et al., 2006).
2.5. Statistical analysis
Data were analyzed using the statistical software package Prism 5
(Chicago, IL, USA) unless otherwise speciﬁed. Despite normal distri-
bution of the data from drinking tests, two-group comparisons were
analyzed with non-parametric Mann–Whitney U test and multiple
group comparisons were treated by non-parametric Kruskal–Wallis
test, since few values were close to the error of measurement and
they were considered as arbitrarily taken. Because of a limited accura-
cy of manual scoring for the forced swim andmodiﬁed tail suspension
behaviors, these data were also analyzed using this method. To com-
pare variances, F test was applied. Body weight, other visually scored
behaviors and the automated scores of the forced swim and modiﬁed
tail suspension were analyzed using an unpaired t-test; the latter
analysis was carried out using CleverSys software (CleverSys, Reston,
VA, USA). The level of conﬁdence was set at 95% (pb0.05).
3. Results
3.1. Experiment 1: study of behavioral measures of hedonic sensitivity in
old versus young mice
3.1.1. Two-bottle sucrose preference test
In Experiment 1, 18-month-old animals showed signiﬁcantly lower
preference to 1% sucrose solution over water (p=0.0005, U=33.0;
Fig. 1A), lower sucrose intake (p=0.0016, U=41.0; Fig. 1B) and a ten-
dency to drink more water (p=0.0704, U=76.5; Fig. 1C) compared to
3-month-old mice. The 24-h water intake in a one-bottle paradigm did
not differ between groups (p=0.39, U=41.5; Fig. 1D), demonstrating
their similar metabolic need for water. Aged mice had a signiﬁcantly
higher body weight (p=0.016, t=12.85, df=28; Fig. 1E) than the
youngmice, suggesting that the above-described differences in sucrose
intake and preference are unrelated to differences in body mass and
caloric requirement. The reproducibility of decreases in sucrose intake
and preference found in 18-month-oldmicewas demonstrated in inde-
pendent experiments; there were no seasonal effects observed in these
studies (data not shown).
3.1.2. Sucrose and water intake in high-effort one-bottle drinking test
In the high-effort one-bottle drinking test, the amount of 5% sucrose
liquid consumed was taken as a measure of the animal's motivation to
receive a pleasurable stimulus. This parameter was signiﬁcantly lower
in 18-month-old mice than in 3-month-old mice (p=0.01, U=3.0;
Fig. 1G). While young mice showed a signiﬁcant increase in 5% sucrose
intake in comparison to intake of water, which was separately evaluat-
ed in a high-effort drinking paradigm (p=0.02, U=21.0; Fig. 1G), older
animals showed no such difference (p>0.05, U=6.0). In this experi-
ment, the two groups of mice showed similar levels of water intake
(p>0.05, U=15.5) suggesting comparable ability to drink from bottles
with narrow tips for 3- and 18-month-old animals. The intake of the 5%
sucrose solution in free-drinking conditions showed no difference be-
tween groups, indirectly demonstrating the undisturbed ability of the
older group to taste the sucrose solution at the concentration employed
(p>0.05, U=15.0; Fig. 1G).
3.2. Experiment 2: study of parameters of behavioral despair during
aging
3.2.1. Forced swim test
Automated analysis revealed no differences between young and
aged groups in the total duration of ﬂoating behavior (p=0.31,
df=26; t-test) and swimming behavior (p=0.26, df=26; data not
shown). Experimental groups showed similar mean values for these
variables measured during one-minute intervals (p>0.05; Fig. 2A).
The duration of climbing and the number of diving events did not dif-
fer between 3- and 18-month-old animals (p=0.93, df=28 and
p=0.11, df=26, respectively; Fig. 2B,C). Aged animals demonstrated
signiﬁcantly higher variability in the latter behavior than young mice
(pb0.0001, F test).
Manual analysis of the forced swim test showed that 3- and
18-month-old mice had similar values of latencies of ﬂoating on
day 1 (3-month-old mice: 92.9±9.3 s, 18-month-old mice: 105.9±
6.6 s; p=0.06, U=74.5) and day 2 (3-month-old mice: 9.1±2.3 s,
18-month-old mice: 11.3±3.3 s; p=0.39, U=105.0; Fig. 3A,C). The
imipramine-treated group had longer latency of ﬂoating than vehicle-
treated mice (day 1: p=0.005, U=29.0, day 2: p=0.0007, U=17.5).
Multiple comparison revealed signiﬁcant differences in the normalized
values of this parameter between three groups of 3-month-old mice
(day 1: p=0.01, Kruskal–Wallis test=8.49; day 2: p=0.004, Kruskal–
Wallis test=10.74). Total duration of ﬂoating was similar in the age
comparison experiment on day 1 (p=0.3, U=87.5, mean values of
ﬂoating in young and oldmice: 154.2±13.7 s and 143.9±12.0 s, respec-
tively) and day 2 (p=0.09, U=71.0, mean values of ﬂoating in young
and old mice: 250.7±10.6 s and 234.1±7.6 s, respectively; Fig. 3B,D).
This parameter was signiﬁcantly lower in imipramine-treated versus
vehicle-treated mice on days 1 and 2 (p=0.004, U=15.0 and p=0.02,
U=23.0, respectively). Multiple comparison revealed signiﬁcant dif-
ferences in normalized values of total duration of ﬂoating between
three groups of 3-month-old mice (day 1: p=0.04, Kruskal–Wallis
test=6.02; day 2: p=0.02, Kruskal–Wallis test=8.14). A comparison
of scores of ﬂoating measured over 1- or 2-min intervals did not reveal
any differences between the groups of two ages (data not shown).
3.2.2. Modiﬁed tail suspension test
Analysis with the CleverSys software found no differences be-
tween 3- and 18-month-old mice in the total duration of immobility
behavior (p=0.18, df=23) and locomotor activity (p=0.12,
df=23; data not shown). Aged and young animals showed no signif-
icant differences in the duration of these behaviors scored during
one-minute intervals (p>0.05; Fig. 2C).
Manual analysis of themodiﬁed tail suspension test indicated that 3-
and 18-month-old mice had no difference in latencies of immobility on
day 1 (3-month-oldmice: 36.4±6.5 s, 18-month-oldmice: 43.3±7.7 s;
p=0.35, U=95.5; Fig. 3E) and day 2 (3-month-old mice: 33.3±6.3 s,
18-month-old mice: 37.1±5.8 s; p=0.32, U=101.0; Fig. 3G). Ani-
mals injected with imipramine demonstrated signiﬁcant increase
of latency of immobility as compared with vehicle-treated mice on
day 1 (p=0.01, U=20.0) and day 2 (p=0.03, U=30.5). Multiple
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comparison revealed signiﬁcant differences in normalized values of
latency of immobility between three groups of 3-month-old mice (day
1: p=0.02, Kruskal–Wallis test=7.11; day 2: p=0.02, Kruskal–Wallis
test=7.96). 3- and 18-month-old mice did not differ in duration of
immobility on day 1 (3-month-old mice: 160.1±10.4 s, 18-month-old
mice: 150.0±9.6 s; p=0.54, U=84.0; Fig. 3F) and day 2 (3-month-
old mice: 242.1±10.7 s, 18-month-old mice: 227.4±8.8 s; p=0.16,
U=78.0; Fig. 3H). Imipramine-treated mice showed decreases in dura-
tion of immobility on days 1 and 2 (p=0.04, U=27.0 and p=0.002,
U=14.0). Similarly to the outcome of the forced swim test, potentially
more sensitive evaluation of both measured parameters at shorter in-
tervals failed to reveal any differences between the groups (data not
shown).
3.3. Experiment 3: study of locomotor, exploration, grooming and
anxiety-like behaviors
3.3.1. True Scan open-ﬁeld and novel cage tests
In the True Scan open-ﬁeld test, the mean speed of movement and
resting time were similar in 3- and 18-month-old mice (p=0.80
df=21 and p=0.54, df=21.0; respectively; Fig. 4A,B). In compari-
son to young mice, older mice displayed a signiﬁcantly reduced dura-
tion of nose poke behavior and rearing activity in the open-ﬁeld test
(p=0.007, df=19 and p=0.02, df=18, respectively; Fig. 4C,D)
and fewer rearings in the novel cage test (p=0.04, df=71; Fig. 4E).
These data demonstrate the lack of locomotor disturbances under
the lighting conditions used in the behavioral studies of 18-month-
Fig. 1. Decreased sucrose intake and preference in 18- versus 3-month-oldmice. In a free-access paradigm, in comparisonwith 3-month-oldmice, 18-month-oldmice exhibited signiﬁcantly
lower sucrose preference (A), decreased sucrose intake (B) and a tendency to increasedwater intake (C) (*pb0.05, 3- vs. 18-month-oldmice;Mann–WhitneyU-test). (D) Twenty-four-hour
water consumption was similar in both groups (p>0.05, 3- vs. 18-month-old mice; Mann–Whitney U-test). (E) Body weight was signiﬁcantly higher in aged mice (*pb0.05, 3- vs.
18-month-old mice; unpaired t-test). (F) In a high-effort drinking test, intake of 5% sucrose solution was signiﬁcantly lower in 18-month-old mice than in 3-month-old mice
(*pb0.05, 3- vs. 18-month-old mice; Mann–Whitney U-test). The young mice showed signiﬁcantly higher consumption of 5% sucrose solution than intake of water (#pb0.05, intake
of water vs. 5% sucrose solution, 3-month-old mice, Mann–Whitney U-test); older animals showed no such difference (p>0.05, intake of water vs. 5% sucrose solution, 18-month-
old mice Mann–Whitney U-test). There was no signiﬁcant difference in water intake between the groups (p>0.05, 3- vs. 18-month-old mice, Mann–Whitney U-test). The intake of
5% sucrose solution in free-drinking conditions did not differ between groups. Bars represent the means of the groups. Each column represents the mean±SEM. 3 MO 3-month-old
mice (A–C: n=15; D–E: n=10; F: n=5); 18 MO: 18-month-old mice (A–C: n=15; D–E: n=10; F: n=5).
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old mice and their lowered exploration of novelty, compared with
3-month-old animals.
3.3.2. Grooming behavior in splash test
Compared with 3-month-old animals, 18-month-old mice exhibited
signiﬁcantly longer latency of the ﬁrst episode of grooming (p=0.03,
U=58.5), lower number of grooming episodes (p=0.04, U=63.5)
and shorter duration of grooming behavior (p=0.02, U=57.0; Fig. 4F).
3.3.3. Anxiety-like behavior
In the O-Maze and Dark/light box paradigms, 18-month-old mice
showed non-signiﬁcantly longer latencies of exit to anxiety-related
areas than 3-month-old mice (p=0.07, df=20 and p=0.69,
df=20, respectively; Fig. 4G,J). Both groups had similar time spent
in open arms (p=0.30, df=20.0; Fig. 4H) and lit compartment
(p=0.40, df=20; Fig. 4K), as well as number of exits to the open
arms (p=0.43, df=20; Fig. 4I) and to the lit box (p=0.83, df=20;
Fig. 4L). These data suggest overall similar scores of anxiety-like
behavior in 3- and 18-month old mice in employed here testing
conditions.
3.4. Experiment 4: effects of imipramine and dimebon in tests for
depressive-like behavior
3.4.1. Sucrose preference test
Baseline testing in the sucrose test (before the onset of chronic
drug administration) revealed signiﬁcantly lower sucrose intake and
preference in 18-month-old than in 3-month-old mice (pb0.0001,
U=2.0 and p=0.0007, U=6.5, respectively; data not shown); older
animals consumed signiﬁcantly more water (p=0.0007, U=6.5),
but their total liquid intake did not differ from that of younger ani-
mals (p=0.10, U=25.0). After chronic dosing, sucrose intake and
preference were signiﬁcantly changed (p=0.003, Kruskal–Wallis sta-
tistic=16.21 and pb0.0001, Kruskal–Wallis statistic=25.21, respec-
tively). In imipramine-treated 18-month-old mice, both parameters
were signiﬁcantly higher than in non-treated mice of this age
(p=0.003, U=2.00; and p=0.002, U=0.00, respectively; Fig. 5A,B).
While these parameters were signiﬁcantly decreased in non-treated 18-
versus 3-month-oldmice (p=0.0007, U=6.5 andpb0.0001, U=2.0, re-
spectively), such differences were not found in aged imipramine-treated
groups (p=0.95, U=24.5 and p=0.59, U=20.0). Treatmentwith imip-
ramine did not affect either of these variables in young mice (p=0.13,
U=19.50 and p=0.36; U=25.0, respectively).
Similarly to imipramine-treated aged mice, 18-month-old mice
dosed with dimebon showed a signiﬁcantly higher sucrose intake
and preference than non-treated mice of this age (p=0.002, U=7.0
and p=0.04, U=17.0; Fig. 5A,B). Sucrose intake in aged dimebon-
treated mice did not differ from that in young mice (p=0.63,
U=43.0), while sucrose preference was signiﬁcantly higher in the
3-month-old group (p=0.002, U=11.0). The latter effect was due
to increased water intake in the dimebon-treated 18-month-old
group versus the 18-month-old non-treated group (p=0.003,
U=8.0). Sucrose preference was signiﬁcantly higher in imipramine-
treated than in dimebon-treated 18-month-old mice (p=0.001,
U=1.0), while sucrose intake did not differ (p=0.85, U=23.0).
Multiple group comparison indicated that water intake was signif-
icantly altered (p=0.0004, Kruskal–Wallis statistic=20.64, Fig. 5C).
Treatment with imipramine did not affect water intake in young ani-
mals (p=0.31, U=24.0) and decreased this variable in old group
(p=0.006, U=2.0); as it is mentioned above, dimebon reduced this
measure in 18-month-old mice (p=0.003, U=8.0). Multiple group
comparison revealed signiﬁcant changes in total intake of liquids
(p=0.01 Kruskal–Wallis statistic =12.55, Fig. 5D); this parameter
was augmented in 18-month-old mice treated with dimebon versus
non-treated aged animals (p=0.003, U=8.0) and was not changed
in imipramine-treated 3-month-old mice (p=0.31, U=24.0) nor in
18-month-old mice (p=0.35, U=13.0, vs. young mice).
3.4.2. Effects of imipramine and dimebon on measures of affective
behavior of young and old mice
Manual scoring of the forced swim test showed that 3- and
18-month-old imipramine-treated mice had higher latency of ﬂoating
than non-treated animals (day 1: p=0.005, U=8.5 and p=0.08,
U=10.0, day 2: p=0.008, U=8 and p=0.007, U=3, respectively;
Fig. 5E,F). No difference between dimebon-treated and non-treated
groups of old mice in this parameter was revealed (day 1: p=0.93,
U=38.5, day 2: p=0.79, U=36.5). Experimental groups 3- and 18-
month-old mice treated with imipramine showed signiﬁcantly de-
creased duration of ﬂoating than non-treated control animals (day 1:
p=0.03, U=16.0 and p=0.04, U=12.50; day 2 (p=0.004, U=6.0
and p=0.005, U=3.0, respectively). A comparison of scores of ﬂoating
measured in dimebon-treated and non-treated 18-month-old mice did
Fig. 2. Automated analysis of the forced swim and modiﬁed tail suspension tests in
young and old mice. (A) In the forced swim test, 3- and 18-month-old mice showed
a similar mean duration of ﬂoating and swimming behaviors scored using the
CleverSys software during one-minute intervals (p>0.05; unpaired t-test). (B) Young
and aged mice showed a similar duration of climbing and (C) number of diving events
(p>0.05; unpaired t-test). (D) In the modiﬁed tail suspension test, groups of aged and
young animals showed no differences in the total duration of immobility behavior and ac-
tivity. Bars represent themeans. 3MO: 3-month-oldmice (n=15); 18MO: 18-month-old
mice (n=15).
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not reveal any differences between the groups (day 1: p=0.73,
U=31.0; day 2: p=0.89, U=38.0).
Similarly to the outcome of the forced swim test, manual analysis
of the modiﬁed tail suspension test revealed the differences between
the same groups. Young and aged imipramine-treated mice showed
signiﬁcantly longer latencies of the immobility as compared with
non-treated control groups (on day 1: p=0.04, U=17.5 and
p=0.02, U=7.0 and day 2: p=0.04, U=17.5 and p=0.02, U=4.0
respectively; Fig. 5G,H). No difference between dimebon-treated
and non-treated groups of old mice in this parameter was found
(day 1: p=1.0, U=31.5, day 2: p=0.86, U=37.5). Imipramine-
treated 3- and 18-month-old mice showed signiﬁcantly decreased
duration of immobility as compared with non-treated control animals
(day 1: p=0.01, U=12.0 and p=0.04, U=8.0, and day 2: p=0.008,
U=8.0 and p=0.003, U=2.0 respectively). This parameter was not
changed in old mice treated with dimebon as compared with non-
treated animals of that age (day 1: p=0.89, U=38.0; day 2:
p=0.45, U=31.0).
4. Discussion
4.1. Anhedonic-like traits of older mice and their reversal by
antidepressant treatment
In a 1% sucrose preference test, 18-month-old mice showed signif-
icantly reduced sucrose intake and preference (Fig. 1A,F) that were
previously shown to correlate with features of depression in stressed
C57BL/6N mice (Strekalova and Steinbusch, 2009, 2010; Strekalova et
al., 2008, 2011; Strekalova, 2008; Tokarski et al., 2009). Such abnor-
malities were not observed in a subset of stressed resilient mice
whose sucrose intake and preference was preserved during stress,
nor in stressed animals chronically treated with antidepressants
imipramine or citalopram. From that, the data obtained here suggest
hedonic deﬁcit in 18-month-old mice. Restoration of normal sucrose
intake and preference in these animals by a 4-week treatment with
the classical antidepressant imipramine (Fig. 5A,B) supports this sug-
gestion. Importantly, the decrease in sucrose preference in 18-month-
old mice occurred at the expense of both a reduction in sucrose intake
(Fig. 1B) and an increase in water consumption (Fig. 1C); the latter ef-
fect was compensatory, as the total liquid intake and 24-h water con-
sumption was unaltered. The concomitance of a decrease in sucrose
intake and preference additionally points to the occurrence of anhe-
donia in older mice.
The amount of highly palatable 5% sucrose solution consumed in a
high-effort drinking paradigm was signiﬁcantly lower in 18-month-
old mice (Fig. 1G); such effects in analogous paradigms are regarded
as a sign of decreased hedonic sensitivity (Hsiao and Chen, 1995). The
similar intake of water in the two groups rules out a potential physi-
cal deﬁcit as a possible confound in the assay. Comparable intake
values of a 5%- sucrose solution in non-restricted drinking conditions
in two groups suggest them to be equally capable of tasting a sucrose
solution. Thus, diminished intake of sucrose solution by aged animals
Fig. 3. Similar ﬂoating and immobility behaviors of visually scored 3- and 18-month-old mice. On both day 1 (A) and day 2 (C) of the forced swim test, imipramine-treated group had
elevated latency of ﬂoating (*pb0.05, vs. vehicle-treated and #pb0.05, vs. non-treated 3-month-old mice); 3- and 18-month-old mice had a similar latency of ﬂoating (p>0.05;
Mann–Whitney U-test). On day 1 (B) and day 2 (D), duration of ﬂoating was lower in imipramine-treated group (*pb0.05, vs. vehicle-treated and #pb0.05, vs. non-treated 3-month-
old mice); and did not differ between 3- and 18-month-old animals (p>0.05; Mann–Whitney U-test). In the modiﬁed tail suspension test, on both day 1 (E) and day 2
(G), imipramine-treated group had elevated latency of immobility (*pb0.05, vs. vehicle-treated and#pb0.05, vs. non-treated 3-month-oldmice); 3- and 18-month-oldmice had a similar
latency of immobility (p>0.05; Mann–Whitney U-test). On day 1 (F) and day 2 (H), duration of immobility was lower in imipramine-treated group (*pb0.05, vs. vehicle-treated and
#pb0.05, vs. non-treated 3-month-old mice); and did not differ between 3- and 18-month-old animals (p>0.05; Mann–Whitney U-test). Bars represent the means. 3 MO: 3-month-
old mice (n=15); 18 MO: 18-month-old mice (n=15); 3 MO-VEH: vehicle-treated 3-month-old mice (n=10); 3 MO-IMI: imipramine-treated 3-month-old mice (n=10).
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Fig. 4. Parameters of locomotion, exploration, grooming and anxiety-like behavior in 3- versus 18-month-old mice. Mean speed (A) and resting time (B) were similar in old and
young mice (p>0.05; unpaired t-test). In comparison to young mice, older mice displayed a signiﬁcantly shorter duration of nose poke behavior (C) and rearing activity (D) in
the open-ﬁeld test (*pb0.05; unpaired t-test), and fewer rearings in the novel cage test (E) (*pb0.05; unpaired t-test). (F) 18-month-old mice showed higher latency of the
ﬁrst episode of grooming, lower number and duration of grooming episodes than 3-month-old mice (*pb0.05; Mann–Whitney U-test). In the O-Maze test, in comparison with
3-month-old mice, 18-month-old animals showed non-signiﬁcantly longer latencies of exit to the open arms (G) and similar values of time spent therein (H) and number of
exits to this area (I) (p>0.05; unpaired t-test). In the dark/light box, there were no differences between the groups in latency of exit to the lit compartment (J) time spent in
this zone (K) or the number of exits to the illuminated box (L) (p>0.05; unpaired t-test). Bars represent the means. 3 MO: 3-month-old mice (A–E and G–L: n=12; F: n=15);
18 MO: 18-month-old mice (A–E and G–L: n=11; F: n=15).
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Fig. 5. (A) Sucrose preference was decreased in non-treated older animals (*pb0.05, old vs. young mice; Mann-Whitney U-test), but not in 18-month-old mice treated with imip-
ramine (p>0.05); it was signiﬁcantly elevated in both treated groups (#pb0.05, vs. 18-month-old non-treated group; Mann-Whitney U-test). Dimebon-treated 18-month-old
group had signiﬁcantly lower sucrose preference than young mice (*pb0.05; Mann-Whitney U-test) and mice of this age that received imipramine (§pb0.05; Mann-Whitney U-
test). (B) Sucrose intake was signiﬁcantly reduced in older group (*pb ;0.05, Mann-Whitney U-test), while aged imipramine- and dimebon-treated animals did not differ from
young mice (p>0.05, vs. 3-month-old mice); sucrose intake was similar in the latter two groups (p>0.05, Mann-Whitney) and signiﬁcantly higher in these groups compared
to non-treated aged mice (#pb0.05, vs. 18-month-old non-treated group; Mann-Whitney U-test). (C) Aged non-treated and dimebon-treated mice showed enhanced water intake
in comparison with young mice (*pb0.05, Mann-Whitney U-test); this was not found in imipramine-treated animals treated with imipramine, which showed a signiﬁcant decrease
in this measure in comparison to the two other 18-month-old groups (#pb0.05; Mann-Whitney U-test). Young imipramine-treated mice had no changes in water consumption
compared to the non-treated animals (p>0.05, Mann-Whitney). (D) Total liquid intake was elevated in all groups of old mice in comparison to young mice (*pb0.05 for
dimebon-treated mice, #pb0.05 for non-treated and §pb0.05 for imipramine-treated mice). Young imipramine-treated mice showed no differences in this parameter. (E) Imipra-
mine-treated mice of both ages had longer latency of ﬂoating and (F) decreased duration of ﬂoating on days 1 and 2 than non-treated groups (*pb0.05, Mann-Whitney U-test).
There were no changes in ﬂoating in dimebon-treated old mice (p>0.05, Mann-Whitney). In the modiﬁed tail suspension test, the latency of immobility (G) was signiﬁcantly lon-
ger and (H) the duration of immobility was signiﬁcantly shorter in imipramine-treated mice of both ages (*pb0.05, Mann-Whitney U-test). Older animals treated with dimebon had
no changes in parameters of immobility (p>0.05, Mann-Whitney). Bars represent the means. 3 MO: non-treated 3-month-old mice (n=10); 3 MO-IMI: 3-month-old mice treated
with imipramine (n=7); 18 MO: 18-month-old mice (n=8); 18 MO-IMI: 18-month-old mice treated with imipramine (n=5); 18 MO-DIM: 18-month-old mice treated with
dimebon (n=10).
561E. Malatynska et al. / Experimental Gerontology 47 (2012) 552–564
Author's personal copy
is likely to be due to their lower motivation for pleasurable stimula-
tion rather than impaired ability to drink from narrow tips or taste
a sweet.
The lack of change in total liquid intake in the sucrose test and 24-h
water consumption in this group (Figs. 1D, 5D) indicates that its physi-
ological need for water is not altered and cannot account for the
observed changes in the sucrose test. The signiﬁcantly higher body
mass in agedmice (Fig. 1E) suggests that the decrease in sucrose intake
is not related to changes in caloric needs; besides, the sucrose test
parameters were shown to be unrelated to individual body weights
(Strekalova et al., 2011). Moreover, 3- and 18-month-old mice dis-
played similar scores for locomotion and anxiety (Fig. 4A,C–G). This is
consistent with the unchanged drinking behavior in novel testing con-
ditions of a high-effort drinking paradigm, showing no indications for
neophobia and psychomotor deﬁcits in aged mice (Fig. 1F). These mea-
surements rule out any essential interference of metabolic, motor and
emotional changes with the evaluation of proposed anhedonic-like be-
havior of 18-month-old mice.
Remarkably, 18-month-old mice displayed less nose-poking be-
havior and a shorter duration of exploratory rearing activity in the
open-ﬁeld test, as well as fewer rearings in the novel cage test
(Fig. 4B–D). Low interest in novelty is regarded as reﬂecting dimin-
ished sensitivity to reward/motivation for hedonic stimulation; it par-
allels elderly depression (Gallo et al., 1997; Bourin et al., 1998) and
can be reversed by antidepressant therapy (Willner, 2005; van
Miegem et al., 2009; American Psychiatric Association, 2000). This
feature generally correlates with aging in rodents (Skrinskaia and
Nikulina, 1994; Schulz et al., 2007; Meier et al., 2010; Sofﬁé et al.,
1992) and particularlywith the occurrence of stress-induced anhedonic
behavior in C57BL6N mice (Strekalova et al., 2004; Porsolt and Papp,
1998). Thus, data on superﬁcial exploration of 18-month-oldmice indi-
rectly support the outcome of the sucrose test.
4.2. Reduced grooming of 18-month-old mice in a splash test
Similarly to the effects of chronic mild stress (Pothion et al., 2004;
Surget et al., 2008), aging was found to result in suppressed grooming
behavior in a classical splash test model: 18-month-old mice exhibited
signiﬁcantly shorter duration of grooming behavior than 3-month-old
animals (Fig. 4F). This feature has been reported to correlate with key
manifestations of a depressive-like state in mice, such as physical ap-
pearance, the choice test, deterioration of the fur state, vanilla pasta
test, reward maze test and others that extensively validate this effect
as an important trait of depressive-like syndrome in mice (Willner,
2005). Similar ﬁndings were reported by other groups (Scimonelli et
al., 1999; Shoji andMizoguchi, 2011). Together, these results are consis-
tent with the above manifestations of depressive-like features of older
mice in sucrose and exploration tests.
4.3. Eighteen-month-old mice display no behavioral signs of affective
disturbances
Both manual and automated scoring of the forced swim and modi-
ﬁed tail suspension tests, whose protocolswere validated in the present
study and in other experiments with various antidepressants under a
number of conditions (van Miegem et al., 2009; Strekalova et al.,
2005, 2006, 2008; Ducottet et al., 2004; Cryan et al., 2005a; Mineur et
al., 2006; Vaugeois et al., 1997; Gavioli et al., 2004; Cryan et al.,
2005b; Ibarguen-Vargas et al., 2009), revealed the lack of differences
between 3- and 18-month-old animals in terms of ﬂoating and immo-
bility measured either during the entire 6-min period (Figs. 2, 3, 5) or
over 1- or 2-min intervals (data not shown). Other behaviors, such as
the duration of swimming behavior/activity (Fig. 2A,D) and the latency
of the ﬁrst episode ofﬂoating/immobility (Fig. 3A,E) also showednodif-
ference between groups. Furthermore, the duration of climbing behav-
ior and diving events during forced swimming, whichwere shown to be
sensitive to some types of antidepressant treatment (Hayashi et al.,
2011), did not differ between the two groups (Fig. 3B,C). The latter pa-
rameter, however, was signiﬁcantly more variable in 18-month-old
mice, with a non-signiﬁcant increase (Fig. 3C) that suggests a trend to-
wards psychomotor disturbances in animals of this age. In summary,
18-month-old mice of the C57BL6/N strain did not demonstrate
changes in measures for affective behaviors in the forced swim and
modiﬁed tail suspension test.
Other reports are consistent with our data. Aging did not change
the ﬂoating behavior of CC57Br, A/He and C3H/He, which were tested
at the age of about 15 months (Skrinskaia and Nikulina, 1994). A lack
of differences in mobility scores in the modiﬁed tail suspension
and forced swim tests was reported in 10- to 15-month-old C57BL6
mice (David et al., 2001; Bourin et al., 1998; Ohashi et al., 2006).
Studies that were predominantly performed on rodents of older age,
however, reported increased ﬂoating and immobility behaviors; the
various outcomes in these tests can be accounted for by the different
age categories. Since most of them evidence higher scores of behav-
ioral despair accompanied by psychomotor deﬁcits, the validity of
these ﬁndings may be limited (Skrinskaia and Nikulina, 1994;
Schulz et al., 2007; Sofﬁé et al., 1992; Bowman et al., 2006).
4.4. Comparison of 3- and 18-month-old mice in additional tests
Similar values for the speed of movement and resting time in the
open-ﬁeld test suggest a lack of motor disturbances in 18-month-
old mice (Fig. 4A,B). The onset, frequency and duration of grooming,
as well as nose-poking behavior, exploratory rearing, and vertical ac-
tivity in the novel cage test were inhibited in 18-month-old mice, in
comparison to a younger group (Fig. 4C–F). As discussed above, decreases
in these behaviors parallel reduced hedonic sensitivity and other
depressive-like features in rodents. Elevated anxiety is awell-known fea-
ture of aging and depressive disorder (American Psychiatric Association,
2000), but not always accompanies anhedonia/depressive syndrome in
clinical and animal studies (Hybels et al., 2011; Pachana et al., 2011;
Sobrian et al., 2003). Our experiments found no evidence of such changes
in 18-month-old mice (Fig. 4G–L). This may be due to the applied here
“mild” protocols of the O-Maze and dark/light box anxiety paradigms
(Strekalova et al., 2005, 2006), while most of studies which reported in-
creased anxiety-like behavior during aging, employ highly anxiogenic
testing (Skrinskaia and Nikulina, 1994; Schulz et al., 2007; Meier et al.,
2010; Lawton et al., 1996). In summary, in the protocols used here for
anxiety-like behaviors and other behavioral analysis, aged mice dis-
played no alterations in measures of anxiety-like behavior and locomo-
tion, excluding possible confounds with evaluation of depressive-like
traits.
4.5. Effects of imipramine and dimebon in old mice
Both drugs elevated sucrose intake and preference in 18-month-old
mice (Fig. 5B) that is characteristic of the effects of antidepressants
(Porsolt and Papp, 1998; Strekalova et al., 2011; van Miegem et al.,
2009). Thus, elderly-related manifestations of anhedonia are reversible
by antidepressant treatment with imipramine that validates the pro-
posed model pharmacologically. In contrast to imipramine, dimebon-
treated mice showed a signiﬁcant increase in the total intake of liquid
(Fig. 5D) that may suggest the emergence of the characteristic anti-
histamine effect of increasing water intake, reported in patients after a
four-week course of dimebon, and in mice after ﬁve-day treatment, at
comparable doses (Vignisse et al., 2011; Bachurin and Grigoriev, 2008;
Magrani et al., 2006). Imipramine reduced water intake that was obvi-
ously owed to the compensation of increased consumption of a sucrose
solution (Fig. 5A–C). Interestingly, dimebon exhibited anti-anxiety ef-
fects in mice and rats (Vignisse et al., 2011; Magrani et al., 2006),
which similarly to the situation with many other drugs, overlap with
its antidepressant action (Porsolt and Papp, 1998; Willner, 2005).
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Further experiments are required to see whether one of the above-
discussed mechanisms (Bolkunov et al., 2009; Strekalova, 2008;
Strekalova and Steinbusch, 2009; Hybels et al., 2011; Bachurin et al.,
2001, 2003) or other effects of dimebon underlie its activity in sucrose
test.
In the modiﬁed protocols of the forced swim andmodiﬁed tail sus-
pension tests, imipramine but not dimebon decreased duration of
ﬂoating and immobilization during testing on both days (Fig. 5D,E).
These effects were found in both young and old mice. The latency of
the ﬁrst episode of ﬂoating was also decreased by imipramine in
mice of both ages; no such effect was found in dimebon-treated
mice. Thus, the effects of antidepressant treatment in the tests for
animal parallels behavioral despair where originally 3- and 18-month-
old mice display similar behavior did not differ between the groups.
5. Conclusions
The present study demonstrates the occurrence of anhedonic-like
traits in 18-month-old mice which are not accompanied by manifes-
tations of behavioral despair and mimic the clinical proﬁle of primary
elderly depression where hedonic deﬁcits outweigh affective symp-
toms. Anhedonic-like changes in older mice found in a sucrose prefer-
ence test were sensitive to a chronic antidepressant treatment and
were accompanied by decreases in sucrose intake in a high-effort
drinking paradigm, grooming in a splash test and novelty exploration.
Additional studies ruled out potential confounds in the analysis of
behavioral features that are speciﬁc to depressive-like syndrome, in
pre-clinical modeling of elderly depression in 18-months-old mice
of this strain.
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